Patent classifications
A61K36/57
COMPOSITIONS FOR INHIBITING DEGRADATION OF HYALURONIC ACID AND METHODS OF USE THEREOF
The present disclosure relates to compositions containing natural plant extracts that inhibit Hyaluronidase 1 and their use in effectively treating conditions such as dryness of skin and lips, skin damage due to UV radiation, chronic inflammatory conditions affecting the skin, the urinary bladder or prostate, osteoarthritis and joint pain, and also promoting wound healing.
COMPOSITIONS FOR INHIBITING DEGRADATION OF HYALURONIC ACID AND METHODS OF USE THEREOF
The present disclosure relates to compositions containing natural plant extracts that inhibit Hyaluronidase 1 and their use in effectively treating conditions such as dryness of skin and lips, skin damage due to UV radiation, chronic inflammatory conditions affecting the skin, the urinary bladder or prostate, osteoarthritis and joint pain, and also promoting wound healing.
Use of <i>Liriodendron chinense </i>(<i>Hemsl</i>.) <i>Sarg</i>. or extract thereof in the preparation of medicament for reducing serum uric acid level and preventing and treating uric acid nephropathy
The present disclosure relates to the field of medicaments, and particularly to use of Liriodendron chinense (Hemsl.) Sarg, or an extract thereof in the preparation of a medicament for reducing a serum uric acid level and preventing and treating uric acid nephropathy, and belongs to the field of medicaments. In one aspect, the present disclosure provides use of Liriodendron chinense (Hemsl.) Sarg. or an extract thereof in the preparation of a medicament for reducing a serum uric acid level. In another aspect, the present disclosure further provides use of Liriodendron chinense (Hemsl.) Sarg. or an extract thereof in the preparation of a medicament for treating and/or preventing uric acid nephropathy.
Use of <i>Liriodendron chinense </i>(<i>Hemsl</i>.) <i>Sarg</i>. or extract thereof in the preparation of medicament for reducing serum uric acid level and preventing and treating uric acid nephropathy
The present disclosure relates to the field of medicaments, and particularly to use of Liriodendron chinense (Hemsl.) Sarg, or an extract thereof in the preparation of a medicament for reducing a serum uric acid level and preventing and treating uric acid nephropathy, and belongs to the field of medicaments. In one aspect, the present disclosure provides use of Liriodendron chinense (Hemsl.) Sarg. or an extract thereof in the preparation of a medicament for reducing a serum uric acid level. In another aspect, the present disclosure further provides use of Liriodendron chinense (Hemsl.) Sarg. or an extract thereof in the preparation of a medicament for treating and/or preventing uric acid nephropathy.